Harvest Group Wealth Management’s Integra LifeSciences IART Stock Holding History

Harvest Group Wealth Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4	Closed	–	–	336
2020 Q4	$0	Hold	4	–	–	﹤0.01%	736
2020 Q3	$0	Hold	4	–	–	﹤0.01%	691
2020 Q2	$0	Hold	4	–	–	﹤0.01%	644
2020 Q1	$0	Sell	4 -174	-98%	-$9.13K	﹤0.01%	714
2019 Q4	$10K	Hold	178	–	–	0.01%	244
2019 Q3	$11K	Sell	178 -36	-17%	-$2.15K	0.01%	242
2019 Q2	$11K	Hold	214	–	–	0.01%	206
2019 Q1	$12K	Buy	+214	New	+$10.9K	0.01%	213

Other funds holding IART

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harvest Group Wealth Management's IART Position: Q1 2021 in Review

Harvest Group Wealth Management sold out of Integra LifeSciences (IART) in Q1 2021, closing a stake of 4 shares.

Harvest Group Wealth Management first reported a position in IART in Q1 2019 and held it in 8 quarters. The position peaked at $12K in Q1 2019. 257 funds tracked by Wall St. Rank hold IART as of Q1 2021.

Harvest Group Wealth Management reported no remaining Integra LifeSciences position as of Q1 2021 after selling out during the quarter.
Harvest Group Wealth Management sold 4 Integra LifeSciences shares in Q1 2021.
Harvest Group Wealth Management first reported a position in Integra LifeSciences in Q1 2019 and held it in 8 quarters.
Harvest Group Wealth Management's Integra LifeSciences position peaked at $12K in Q1 2019.
257 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2021.

Based on Harvest Group Wealth Management's 13F filing for Q1 2021, filed 4 May 2021.